WECAN Academy 2023
At the start of July, one of the Action Kidney [...]
At the start of July, one of the Action Kidney [...]
Sharon Deveson Kell was invited by Cancer52 to represent the [...]
Sharon Deveson Kell represented the kidney cancer community at the [...]
Immunotherapy combinations are becoming the standard treatment after surgery for [...]
TIVO-3 was a phase 3 clinical trial that compared tivozanib, [...]
Adjuvant therapy aims to reduce the risk of the cancer [...]
Stereotactic ablative radiotherapy (SABR) for treating the primary kidney cancer [...]
Patients with advanced cancer want to live a good quality [...]
This study looked at the incidence, diagnosis and treatment of [...]
The standard treatment for small renal masses is to remove [...]